Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.09

-8.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote ()	9/2/1999 9:11:00 PM
From: bakerable	of 32384

This is my first post. I have followed Seragen's technology since 1993. I feel that the technology is greatly underestimated due to the manner in which the company was controlled and managed. I recently picked up some anecdotal evidence about the efficacy of ONTAK from a knowledgeable friend who had spoken to a dermatologist who is administering Ontak to more that one patient with advanced CTCL. The doctor expressed complete satisfaction with the safety and side effect profile in the cases which he had treated. He described Ontak as a very good medication. Two thoughts come out of this 1) Dermatologists will administer a therapy requiring infusion and 2) if Ontak is working in advanced CTCL it will work even better in earlier stages of the disease and it will also work in Non-Hodgkins Lymphoma. Ontak received a very bad rap re side effects. Based on my following of this drug through trials I don't feel it was deserved. This seems to be the experience of one doctor in the real world.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next